Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.
about
Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillanceGastric cancer: descriptive epidemiology, risk factors, screening, and preventionGastric cancer: prevention, screening and early diagnosisDiagnosis and management of high risk group for gastric cancerGastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts.Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsConsensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.Using stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration.Screening for and surveillance of gastric cancer.Prevention strategies for gastric cancer: a global perspectiveA cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk.Endoscopic surveillance of gastrointestinal premalignant lesions: current knowledge and future directionsBiomarkers of Helicobacter pylori-associated gastric cancer.Helicobacter pylori: evidence-based review with a focus on immigrant populations.Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed?Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions.Helicobacter pylori and public health.Implementation of gastric cancer screening - the global experience.Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study.H. pylori Management in ASEAN: the Bangkok Consensus Report.Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults.Clinical risk assessment for gastric cancer in asymptomatic population after a health check-up: An individualized consideration of the risk factors.Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the nationwide reimbursement database.Low yield for non-targeted biopsies of the stomach and esophagus during elective esophagogastroduodenoscopy.Higher risk of gastric cancer among immigrants to Ontario: a population-based matched cohort study with over 2 million individuals.Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk.Bone morphogenetic protein and activin membrane-bound inhibitor overexpression inhibits gastric tumor cell invasion via the transforming growth factor-β/epithelial-mesenchymal transition signaling pathway.UEG Week 2015 Poster PresentationsMixed lineage kinase-4 promotes gastric carcinoma tumorigenesis through suppression of the c-Jun N-terminal kinase signaling pathway
P2860
Q26774447-1DCBFE34-1D72-44AC-BF50-2184DD8D0DBCQ26849435-81570D19-2F4F-4208-9495-BFFF474AABD5Q26860418-179101FE-8FA6-4466-A95C-B4F25AD3389AQ28084323-684A1FC5-636E-4767-94E7-DE50E46DDB91Q30250102-9DA5E92E-E801-414B-9544-368994E43F91Q33594937-16085102-EA81-488F-90B3-12CAC16A2A22Q33636554-CEE1CD95-9E6F-4897-BE81-7ED2CC01958AQ33698340-7E186C69-918D-4095-A68B-4D4FA0E1B0CDQ33911623-3CD989DA-47C8-4985-81C2-B6F7BFE7E68BQ34277478-26155799-91CD-4E82-A30C-98F7505EA403Q34326563-F9CB3F97-90DE-4887-AF7D-438B3786C872Q34658645-355DF2A4-5277-4F48-B0DE-BBA76EE73DE1Q35080762-E7E821EF-D796-4D9E-969D-BC29D88FE97BQ35086878-A428A0D5-32BF-41AE-83CA-174E00BFE840Q37591506-57D927F8-AC6A-411B-BE28-BAC3EB478329Q37595765-42CCCA2E-3975-416C-9E07-B7F2707B3022Q38150281-A81F2BFD-4010-4365-B787-CAF96A2F8197Q38244069-3D67208F-F1A3-4D62-A465-D7827A06AF9FQ38244262-BB85092A-3167-4132-A598-9C17BA890EF1Q38273499-6827D798-5611-47E6-8479-74EE37B422FEQ38628238-CA813748-C2B2-4191-A302-9AD133EF0686Q40100019-21C5F02D-E93F-45FE-A5F2-2F5FF4C48D11Q40114688-412841FC-2C7B-4369-B25A-95C02102E58CQ40446747-B962379D-D6FE-455F-8156-19B0F398CCD4Q41670325-D94BE038-FF2C-4612-AA10-D198DC7E9131Q45968149-4C338047-991B-414C-AE9F-D21DDF25AF44Q47559361-D972551A-15E2-4F1F-96C8-814F2D40522AQ55029990-C129FF79-F7ED-4C7B-8564-F2AF6369BBE4Q55409931-AEFEB79D-0499-4E22-8FC2-90445EDEA623Q56934656-85A98F50-AAB4-4A19-B748-295495776E92Q58733361-246645D2-E878-46B9-B413-7754F27A5AA9
P2860
Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Screening for gastric cancer a ...... of cost-effectiveness studies.
@en
type
label
Screening for gastric cancer a ...... of cost-effectiveness studies.
@en
prefLabel
Screening for gastric cancer a ...... of cost-effectiveness studies.
@en
P2093
P2860
P356
P1433
P1476
Screening for gastric cancer a ...... of cost-effectiveness studies
@en
P2093
Ana Teresa Cadime
Francisco Rocha Gonçalves
Rita Carvalho
P2860
P304
P356
10.1111/HEL.12050
P577
2013-04-09T00:00:00Z